Green Bioactives, the plant biotechnology start-up which opened at the beginning of the pandemic, has secured two new international contracts, as it gears up to launch its first consumer product later this year.
The Roslin-based company will supply its biochemicals – derived from plant materials which are key ingredients in a variety of food, pharmaceutical and cosmetic products – to a major US chemical company and a Chinese pharmaceuticals manufacturer.
After recently receiving regulatory approval, Green Bioactives is also targeting the launch of a memory-enhancing supplement – commonly referred to as nootropics – in the autumn.
Made from natural plant molecules, it will be the only clinically-trialled product of its kind.
The company has been supported in its development by the Industrial Biotechnology Innovation Centre (IBioIC).
Green Bioactives used the innovation centre’s Bioprocessing Scale Up Centres to increase the production volume of its cultured plant cells, helping to scale production from 50 millilitre laboratory flasks to 20 litre commercial containers.
Gary Loake, chief executive and co-founder of Green Bioactives, said: “Winning these two contracts is validation of the technology we have been developing and our products’ relevance to a variety of international markets.
“The regulatory approval of our consumer nootropics offering is another highly positive piece of news – when it launches later this year the product will act as another important revenue stream for us as we diversify the business.
“We expect it to be available through a number of well-known retailers, and are in talks to make that happen as we raise more business and make more connections.”
Neil Renault, biofacilities and operations manager at IBioIC, said: “Biotechnology companies can often face challenge around scaling their products, with performance changing as you increase production volumes and, with that, the need to use new and larger pieces of equipment.
“Our facilities are about giving small companies and start-ups access to what they need in the early stages of their development, when how they deploy their capital is incredibly important.
“There are a lot of exciting Scottish biotechnology companies working with natural materials that have global potential – we look forward to seeing how Green Bioactives develops and continuing our support for the business.”
Don’t miss the latest headlines with our twice-daily newsletter – sign up here for free.